# Tranexamic Acid in Reverse Total Shoulder Arthroplasty

> **NCT02043132** · PHASE2,PHASE3 · COMPLETED · sponsor: **Corewell Health East** · enrollment: 116 (actual)

## Conditions studied

- Shoulder Joint Disease
- Complications; Arthroplasty
- Intraoperative Complications
- Blood Loss, Surgical

## Interventions

- **DRUG:** Tranexamic Acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02043132
- **Lead sponsor:** Corewell Health East
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-02
- **Target enrollment:** 116 (ACTUAL)
- **Last updated:** 2017-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02043132

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02043132, "Tranexamic Acid in Reverse Total Shoulder Arthroplasty". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02043132. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*